Related Experiment Video

Updated: Jul 16, 2026

Handling of the Cotton Rat in Studies for the Pre-clinical Evaluation of Oncolytic Viruses
06:13

Handling of the Cotton Rat in Studies for the Pre-clinical Evaluation of Oncolytic Viruses

Published on: November 24, 2014

Viral oncoapoptosis of human tumor cells

M Aubert1, J A Blaho

  • 1Department of Microbiology, Mount Sinai School of Medicine, New York, NY 10029-6574, USA.

Gene Therapy
|August 6, 2003
PubMed

Insights

Replication-defective herpes simplex virus triggers cancer cell death by inducing apoptosis. This virus-based therapy shows promise for treating cancers resistant to conventional treatments, targeting cells with modified p53 protein.

Area of Science:

  • Oncology
  • Virology
  • Genetics

Background:

  • Many cancers resist radiation and chemotherapy due to impaired apoptosis regulation.
  • Conventional therapeutics are often ineffective against these refractory cancers.

Purpose of the Study:

  • To investigate the potential of replication-defective delta27 herpes simplex virus (rd delta27) as a therapeutic agent for cancer.
  • To determine if rd delta27 can induce apoptosis in human cancer cells and identify factors influencing susceptibility.

Main Methods:

  • Treatment of three transformed human cell lines with rd delta27.
  • Analysis of p53 protein abundance and distribution in tumor cells.
  • Comparison of rd delta27-induced cell death with apoptosis induced by nonviral factors in primary fibroblast cells.

Main Results:

  • rd delta27 successfully triggered apoptosis in tested human cancer cell lines.
  • Cancer cell susceptibility to rd delta27 was linked to modified p53 protein levels.
  • Normal fibroblast cells with functional p53 were resistant to rd delta27 but susceptible to other apoptotic stimuli.

Conclusions:

  • Nonreplicating virus-induced apoptosis is a viable genetic therapy strategy for human cancers.
  • rd delta27 demonstrates potential for targeted cancer treatment, particularly in cancers with specific p53 modifications.
  • Findings support the development of novel virus-based anticancer strategies.

More Related Videos

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy08:51

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells09:57

Real Time Detection of In Vitro Tumor Cell Apoptosis Induced by CD8+ T Cells to Study Immune Suppressive Functions of Tumor-infiltrating Myeloid Cells

Published on: January 29, 2019

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.